Next Article in Journal
Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives
Next Article in Special Issue
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Previous Article in Journal
Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative
 
 
Article

Article Versions Notes

Pharmaceutics 2026, 18(5), 555; https://doi.org/10.3390/pharmaceutics18050555
Action Date Notes Link
article html file updated 3 September 2026 16:04 CEST Update https://www.mdpi.com/1999-4923/18/5/555/html
article html file updated 14 May 2026 19:30 CEST Update -
article html file updated 14 May 2026 06:32 CEST Original file -
article pdf uploaded. 14 May 2026 06:30 CEST Updated version of record https://www.mdpi.com/1999-4923/18/5/555/pdf
article xml uploaded. 14 May 2026 06:30 CEST Update https://www.mdpi.com/1999-4923/18/5/555/xml
article xml file uploaded 14 May 2026 06:30 CEST Original file -
article supplementary file uploaded. 30 April 2026 15:24 CEST - https://www.mdpi.com/1999-4923/18/5/555#supplementary
article pdf uploaded. 30 April 2026 15:24 CEST Version of Record https://www.mdpi.com/1999-4923/18/5/555/pdf-vor
Back to TopTop